Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1080/21645515.2020.1787068 http://scihub22266oqcxt.onion/10.1080/21645515.2020.1787068 32755425!8641599!32755425     free     free     free Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 251.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Hum+Vaccin+Immunother 2020 ; 16 (12): 2992-3000 Nephropedia Template TP {{tp|p=32755425|t=2020. Coronavirus disease 2019-Historical context, virology, pathogenesis, immunotherapy, and vaccine development |pdf=|usr=}}{{32755425}} gab.com Text Coronavirus disease 2019-Historical context, virology, pathogenesis, immunotherapy, and vaccine development JO: Hum Vaccin Immunother http://www.kidney.de/pget.php?&tw=1&pmid=32755425 #FOAvip The current Coronavirus Disease 2019 (COVID-19) pandemic is causing great alarm around the world. The pathogen for COVID-19 - severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) - is the seventh known coronavirus to cause pneumonia in humans. While much remains unknown about SARS-CoV-2, physicians and researchers have begun to publish relevant findings, and much evidence is available on coronaviruses previously circulating in human and animal populations. In this review, we situate COVID-19 in its context as a transboundary viral disease, and provide a comprehensive discussion focused on the discovery, spread, virology, pathogenesis, and clinical features of this disease, its causative coronaviral pathogen, and approaches to combating the disease through immunotherapies and other treatments and vaccine development. An epidemiological survey revealed a potentially large number of asymptomatic SARS-CoV-2 carriers within the population, which may hamper efforts against COVID-19. Finally, we emphasize that vaccines against SARS-CoV-2, which may be developed by 2021, will be essential for prevention of COVID-19. Twit Text FOAVip Coronavirus disease 2019-Historical context, virology, pathogenesis, immunotherapy, and vaccine development ????Hum Vaccin Immunother http://www.kidney.de/pget.php?&tw=1&pmid=32755425 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32755425 #FOAvip English Wikipedia <ref>{{Cite pmid|32755425}}</ref> Coronavirus disease 2019-Historical context, virology, pathogenesis, immunotherapy, and vaccine development #MMPMID32755425 Ezzikouri S; Nourlil J; Benjelloun S; Kohara M; Tsukiyama-Kohara K Hum Vaccin Immunother 2020[Dec]; 16 (12): 2992-3000 PMID32755425show ga The current Coronavirus Disease 2019 (COVID-19) pandemic is causing great alarm around the world. The pathogen for COVID-19 - severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) - is the seventh known coronavirus to cause pneumonia in humans. While much remains unknown about SARS-CoV-2, physicians and researchers have begun to publish relevant findings, and much evidence is available on coronaviruses previously circulating in human and animal populations. In this review, we situate COVID-19 in its context as a transboundary viral disease, and provide a comprehensive discussion focused on the discovery, spread, virology, pathogenesis, and clinical features of this disease, its causative coronaviral pathogen, and approaches to combating the disease through immunotherapies and other treatments and vaccine development. An epidemiological survey revealed a potentially large number of asymptomatic SARS-CoV-2 carriers within the population, which may hamper efforts against COVID-19. Finally, we emphasize that vaccines against SARS-CoV-2, which may be developed by 2021, will be essential for prevention of COVID-19. |Animals[MESH] |COVID-19/epidemiology/*immunology/*prevention & control[MESH] |Drug Development/*methods/trends[MESH] |Humans[MESH] |Immunotherapy/methods/*trends[MESH]Coronavirus disease 2019-Historical context, virology, pathogenesis, (epmc).pdf DeepDyve Pubget Overpricing